Lipids in Health and Disease

Table 1 Lipid concentrations in cases (FCH patients) and controls.

From: Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene

	FCH Patients	Controls	P value*
Total cholesterol	238.67 ± 50.10	185.13 ± 28.30	0.001
Triglycerides	204.71 ± 192.16	88.27 ± 42.45	0.001
LDLc	156.85 ± 39.97	113.50 ± 25.20	0.001
HDLc	47.77 ± 17.18	53.93 ± 14.48	0.001
VLDLc	40.28 ± 36.52	17.65 ± 8.49	0.001
Non-HDLc	192.94 ± 48.68	131.50 ± 29.09	0.001
Apo AI	133.55 ± 32.52	152.79 ± 29.03	0.001
Apo B100	125.80 ± 28.11	95.25 ± 21.15	0.001
LDL diameter	25.45 ± 0.78	26.14 ± 0.74	0.001

* ANOVA Test
Values are expressed as mean ± standard deviation. Units are mg/dL in all parameters except LDL diameter (nm).

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com